Edoardo Caronna

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 80 publications

EMHA migraine scoring system: A novel, valid, and reliable metric to capture severity, align with patients, and facilitate communication.

EMHA migraine scoring system: A novel, valid, and reliable metric to capture severity, align with patients, and facilitate communication.

Journal: Cephalalgia : an international journal of headache

Published: September 02, 2026

Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort.

Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort.

Journal: Cephalalgia : an international journal of headache

Published: June 19, 2026

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Journal: Neurology

Published: May 27, 2026

Erenumab and OnabotulinumtoxinA in Chronic Migraine: A Comparative Analysis.

Erenumab and OnabotulinumtoxinA in Chronic Migraine: A Comparative Analysis.

Journal: European journal of neurology

Published: February 15, 2026

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Journal: Neurology

Published: January 28, 2026

2025 highlights from real world studies in migraine.

2025 highlights from real world studies in migraine.

Journal: Cephalalgia : an international journal of headache

Published: January 23, 2026

Multimodal serum and MRI signatures of neuroaxonal injury in high-frequency migraine.

Multimodal serum and MRI signatures of neuroaxonal injury in high-frequency migraine.

Journal: The journal of headache and pain

Published: January 16, 2026

Brain structural MRI changes before and after 6 months of preventive treatment with erenumab and onabotulinumtoxinA in migraine.

Brain structural MRI changes before and after 6 months of preventive treatment with erenumab and onabotulinumtoxinA in migraine.

Journal: The journal of headache and pain

Published: December 15, 2025

The interplay between migraine, endometriosis and polycystic ovarian syndrome: A systematic review.

The interplay between migraine, endometriosis and polycystic ovarian syndrome: A systematic review.

Journal: Cephalalgia : an international journal of headache

Published: December 12, 2025

The Association of Headache and Physical Activity in Times of the COVID-19 Pandemic: A Prospective Cohort Study.

The Association of Headache and Physical Activity in Times of the COVID-19 Pandemic: A Prospective Cohort Study.

Journal: Brain and behavior

Published: December 08, 2025

Combination preventive therapy with onabotulinumtoxinA and atogepant for chronic migraine: A 24-week, prospective, real-world evaluation (SYNERGY study).

Combination preventive therapy with onabotulinumtoxinA and atogepant for chronic migraine: A 24-week, prospective, real-world evaluation (SYNERGY study).

Journal: Cephalalgia : an international journal of headache

Published: December 02, 2025

Central and Peripheral Sensitization in Temporomandibular Disorders: Proposed Mechanisms of Botulinum Toxin Therapy.

Central and Peripheral Sensitization in Temporomandibular Disorders: Proposed Mechanisms of Botulinum Toxin Therapy.

Journal: Toxins

Published: November 21, 2025

Showing 1-12 of 80

Last Updated: 09/26/2026